Current status of the satisfaction levels of adult patients receiving drugs for atopic dermatitis and chronic urticaria

Medicine and Dentistry

• Satisfaction 83%
• Adult 50%
• Therapeutic Procedure 50%
• Atopic Dermatitis 50%
• Chronic Urticaria 50%
• Combination Therapy 25%
• Drug 16%
• Chemotherapeutic Agent 16%
• Biological Product 16%
• Dupilumab 16%
• Drug Therapy 8%
• Histamine Antagonist 8%
• Skin Allergy 8%
• Tacrolimus 8%
• Patient Characteristics 8%
• Patient Satisfaction 8%
• Dermatology Life Quality Index 8%

Nursing and Health Professions

• Patient 100%
• Atopic Dermatitis 50%
• Chronic Urticaria 50%
• Combination Therapy 25%
• Standard 16%
• Quality of Life 16%
• Biological Product 16%
• Drug 16%
• Dupilumab 16%
• Procedures 8%
• Confounding Factor 8%
• Skin Allergy 8%
• Antihistaminic Agent 8%
• Tacrolimus 8%
• Multiple Choice Test 8%
• Dermatology Life Quality Index 8%
• Omalizumab 8%